Cargando…

Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis

PURPOSE: Glypican-3 (GPC-3) expression is abnormal in the occurrence and development of hepatocellular carcinoma (HCC). To explore whether GPC-3 has diagnostic accuracy and prognostic significance of HCC, we did a systematic review and meta-analysis. METHOD: PubMed, Embase, Cochrane Library, and Chi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Donglei, Zhang, Yingshi, Wang, Yinuo, Xu, Fu, Liang, Jun, Wang, Weining
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539414/ https://www.ncbi.nlm.nih.gov/pubmed/36212469 http://dx.doi.org/10.3389/fonc.2022.1012418

Ejemplares similares

Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis
por: Xiao, Wei-Kai, et al.
Publicado: (2014)

Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis
por: Liu, Hong, et al.
Publicado: (2018)

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
por: Zheng, Xiufeng, et al.
Publicado: (2022)

Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma
por: Wang, Jian-Yao, et al.
Publicado: (2021)

Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma
por: Liu, Peijun, et al.
Publicado: (2023)

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
por: El-Saadany, Sherif, et al.
Publicado: (2018)

Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging
por: Zhang, Ning, et al.
Publicado: (2023)

Reduced tumor stiffness quantified by tomoelastography as a predicative marker for glypican-3-positive hepatocellular carcinoma
por: Wang, Yihuan, et al.
Publicado: (2022)

The expression of Ki-67 and Glypican -3 in hepatocellular carcinoma was evaluated by comparing DWI and (18)F-FDG PET/CT
por: Wang, Xuedong, et al.
Publicado: (2023)

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of heat shock proteins in hepatocellular carcinoma: a systematic review and meta-analysis
por: Xiang, Dan, et al.
Publicado: (2023)

The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis
por: Zhu, Guang, et al.
Publicado: (2021)

Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles
por: Aishanjiang, Kedeerya, et al.
Publicado: (2021)

Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma
por: Yan, Jiayao, et al.
Publicado: (2021)

Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
por: Sun, Bin, et al.
Publicado: (2017)

The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
por: Wang, Sen, et al.
Publicado: (2019)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
por: Nishida, Takahiro, et al.
Publicado: (2019)

Significance of exosomes in hepatocellular carcinoma
por: Wang, GuoYun, et al.
Publicado: (2022)

Diagnosis Accuracy and Prognostic Significance of the Dickkopf-1 Protein in Gastrointestinal Carcinomas: Systematic Review and Network Meta-analysis
por: Jiang, Xiaowen, et al.
Publicado: (2020)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Neuroendocrine Tumors Show Altered Expression of Chondroitin Sulfate, Glypican 1, Glypican 5, and Syndecan 2 Depending on Their Differentiation Grade
por: García-Suárez, Olivia, et al.
Publicado: (2014)

The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis
por: Zhao, Shoujie, et al.
Publicado: (2020)

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
por: Wang, Li, et al.
Publicado: (2016)

The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients
por: Liang, Yuxin, et al.
Publicado: (2022)

A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma
por: Song, Yan, et al.
Publicado: (2023)

Next-Generation Cancer Immunotherapy Targeting Glypican-3
por: Shimizu, Yasuhiro, et al.
Publicado: (2019)

Expression Status and Prognostic Significance of Gamma-Glutamyl Transpeptidase Family Genes in Hepatocellular Carcinoma
por: Tian, Shan, et al.
Publicado: (2021)

Little things with significant impact: miRNAs in hepatocellular carcinoma
por: Li, Jiehan, et al.
Publicado: (2023)

Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma(☆)
por: Shih, Tsung-Chieh, et al.
Publicado: (2020)

Diagnostic Accuracy of Artificial Intelligence Based on Imaging Data for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhang, Jian, et al.
Publicado: (2022)

Systematic Review With Meta-Analysis: Diagnostic, Prognostic and Clinicopathological Significance of CircRNA Expression in Renal Cancer
por: Wang, Wujun, et al.
Publicado: (2022)

Identification of the mitophagy-related diagnostic biomarkers in hepatocellular carcinoma based on machine learning algorithm and construction of prognostic model
por: Tu, Dao-yuan, et al.
Publicado: (2023)

What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis
por: Hui, Fuhai, et al.
Publicado: (2022)

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
por: Bell, Meghan M., et al.
Publicado: (2020)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
por: Xu, Shaohua, et al.
Publicado: (2022)

Accuracy Evaluation and Comparison of 14 Diagnostic Markers for Nasopharyngeal Carcinoma: A Meta-Analysis
por: Feng, Yiwei, et al.
Publicado: (2020)

Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver
por: Geramizadeh, Bita, et al.
Publicado: (2015)

Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
por: Dai, Weiyu, et al.
Publicado: (2021)

Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta‐analysis
por: Zhang, Yu, et al.
Publicado: (2019)

Accuracy of Various Forms of Contrast-Enhanced MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhao, Chun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4nle89olfun1e58llt5n9lcv26